CONMED Corp. CEO Joseph Corasanti Sells 44,852 Shares (CNMD)
CONMED Corp. (NASDAQ:CNMD) CEO Joseph Corasanti sold 44,852 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $33.04, for a total transaction of $1,481,910.08. Following the transaction, the chief executive officer now directly owns 114,148 shares of the company’s stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
A number of analysts have recently weighed in on CNMD shares. Analysts at Needham & Company initiated coverage on shares of CONMED Corp. (NASDAQ:CNMD) in a research note to investors on Wednesday, September 4th. They set a “buy” rating and a $37.00 price target on the stock. Separately, analysts at Piper Jaffray Cos. raised their price target on shares of CONMED Corp. (NASDAQ:CNMD) from $34.00 to $36.00 in a research note to investors on Thursday, July 25th. They now have a “neutral” rating on the stock. Finally, analysts at Ladenburg Thalmann raised their price target on shares of CONMED Corp. (NASDAQ:CNMD) from $36.25 to $42.00 in a research note to investors on Thursday, July 25th. They now have a “buy” rating on the stock. They noted that the move was a valuation call.
Shares of CONMED Corp. (NASDAQ:CNMD) traded up 0.91% on Monday, hitting $33.30. 118,517 shares of the company’s stock traded hands. CONMED Corp. has a one year low of $25.39 and a one year high of $34.86. The stock has a 50-day moving average of $32.35 and a 200-day moving average of $32.42. The company has a market cap of $915.4 million and a P/E ratio of 23.40.
CONMED Corp. (NASDAQ:CNMD) last released its earnings data on Wednesday, July 24th. The company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by $0.01. The company had revenue of $193.00 million for the quarter, compared to the consensus estimate of $193.55 million. During the same quarter in the previous year, the company posted $0.43 earnings per share. The company’s revenue for the quarter was up 1.7% on a year-over-year basis. On average, analysts predict that CONMED Corp. will post $1.82 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, October 4th. Shareholders of record on Monday, September 16th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 1.80%. The ex-dividend date is Thursday, September 12th.
CONMED Corporation (NASDAQ:CNMD) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.